Granahan Investment Management, LLC Repligen Corp Transaction History

Granahan Investment Management, LLC

$2.12 Billion
Q4 2024

A detailed history of Granahan Investment Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Granahan Investment Management, LLC holds 107,415 shares of RGEN stock, worth $17.5 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares

107,415

Previous 88,255 21.71%

Holding current value

$17.5 Million

Previous $13.1 Million 17.72%

% of portfolio

0.73%

Previous 0.55%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$123.41 - $160.92 $2.36 Million - $3.08 Million	19,160 Added 21.71%	107,415 $15.5 Million
Q3 2024 Nov 14, 2024	BUY	$119.79 - $167.35 $10.6 Million - $14.8 Million	88,255 New	88,255 $13.1 Million
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $840,408 - $1.03 Million	-4,921 Reduced 3.79%	124,765 $22.9 Million
Q4 2023 Feb 14, 2024	SELL	$114.17 - $185.35 $350,730 - $569,395	-3,072 Reduced 2.31%	129,686 $23.3 Million
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $2.5 Million - $3.18 Million	-18,014 Reduced 11.95%	132,758 $21.1 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $5.49 Million - $7.15 Million	39,632 Added 35.66%	150,772 $21.3 Million
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $535,899 - $688,199	3,474 Added 3.23%	111,140 $18.7 Million
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $6.55 Million - $8.9 Million	40,344 Added 59.93%	107,666 $18.2 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $9 Million - $14.4 Million	-56,100 Reduced 45.45%	67,322 $12.6 Million
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $14.1 Million - $18.8 Million	99,947 Added 425.76%	123,422 $20 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $3.78 Million - $6.06 Million	23,475 New	23,475 $4.42 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $774,405 - $1.29 Million	-3,976 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $5.4 Million - $7.19 Million	-32,552 Reduced 89.12%	3,976 $794,000
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $1.78 Million - $2.23 Million	9,847 Added 36.91%	36,528 $7.1 Million
Q4 2020 Feb 12, 2021	SELL	$148.08 - $206.57 $15.3 Million - $21.3 Million	-103,269 Reduced 79.47%	26,681 $5.11 Million
Q3 2020 Nov 12, 2020	SELL	$122.51 - $158.27 $4.57 Million - $5.9 Million	-37,281 Reduced 22.29%	129,950 $19.2 Million
Q2 2020 Aug 14, 2020	SELL	$94.33 - $140.48 $3.38 Million - $5.04 Million	-35,883 Reduced 17.67%	167,231 $21.3 Million
Q1 2020 May 12, 2020	SELL	$84.96 - $109.14 $3.28 Million - $4.21 Million	-38,552 Reduced 15.95%	203,114 $19.6 Million
Q4 2019 Feb 14, 2020	SELL	$73.84 - $93.08 $75,464 - $95,127	-1,022 Reduced 0.42%	241,666 $22.4 Million
Q3 2019 Nov 15, 2019	SELL	$76.65 - $95.51 $1 Million - $1.25 Million	-13,067 Reduced 5.11%	242,688 $18.6 Million
Q2 2019 Aug 14, 2019	SELL	$54.2 - $85.95 $1.19 Million - $1.89 Million	-22,041 Reduced 7.93%	255,755 $22 Million
Q1 2019 May 14, 2019	BUY	$49.45 - $62.8 $593,103 - $753,223	11,994 Added 4.51%	277,796 $16.4 Million
Q4 2018 Feb 13, 2019	SELL	$48.26 - $68.88 $73,065 - $104,284	-1,514 Reduced 0.57%	265,802 $14 Million
Q3 2018 Nov 13, 2018	BUY	$46.8 - $58.97 $4.17 Million - $5.26 Million	89,157 Added 50.04%	267,316 $14.8 Million
Q2 2018 Aug 15, 2018	BUY	$35.26 - $47.04 $678,049 - $904,579	19,230 Added 12.1%	178,159 $8.38 Million
Q1 2018 May 14, 2018	BUY	$30.92 - $37.27 $4 Million - $4.82 Million	129,230 Added 435.13%	158,929 $5.75 Million
Q4 2017 Feb 12, 2018	BUY	$32.53 - $38.92 $966,108 - $1.16 Million	29,699	29,699 $1.08 Million

Others Institutions Holding RGEN

# of Institutions

481

Shares Held

56.3M

Call Options Held

251K

Put Options Held

458K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.03B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Account

Granahan Investment Management, LLC Repligen Corp Transaction History